Pages that link to "Q40802281"
Jump to navigation
Jump to search
The following pages link to Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations (Q40802281):
Displaying 50 items.
- Challenge of changing nursing home prescribing culture (Q26865397) (← links)
- Optimising drug utilisation in long term care (Q28192689) (← links)
- Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. (Q33203719) (← links)
- Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. (Q33483929) (← links)
- Automated pharmacy databases and behavioral health care quality assurance. (Q33583198) (← links)
- Variation in psychotropic drug use in nursing homes (Q33583695) (← links)
- Impact of legislation on nursing home care in the United States: lessons for the United Kingdom (Q33798248) (← links)
- Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context (Q33910629) (← links)
- Incidence and preventability of adverse drug events in nursing homes (Q33916130) (← links)
- Antipsychotic use among nursing home residents (Q33924005) (← links)
- Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. (Q33960193) (← links)
- Use of sleep-promoting medications in nursing home residents : risks versus benefits (Q33996224) (← links)
- Regulation and mindful resident care in nursing homes (Q34054412) (← links)
- An electronic health record driven algorithm to identify incident antidepressant medication users (Q34100018) (← links)
- The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: The Oregon experience (Q34123276) (← links)
- State regulatory enforcement and nursing home termination from the medicare and medicaid programs (Q34293168) (← links)
- The effectiveness of quality systems in nursing homes: a review (Q34462964) (← links)
- Psychotropic medication use for behavioral symptoms of dementia (Q34577786) (← links)
- Pressure ulcer prevalence in long-term nursing home residents since the implementation of OBRA '87. Omnibus Budget Reconciliation Act. (Q34619269) (← links)
- Evaluation of clinical practice guidelines (Q34712849) (← links)
- The drive for quality care in US nursing homes in the era of the prospective payment system (Q34967141) (← links)
- Sleep disorders in Alzheimer's disease and other dementias (Q35839178) (← links)
- Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been? (Q36102230) (← links)
- Relapse risk after discontinuation of risperidone in Alzheimer's disease (Q36375421) (← links)
- A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use. (Q36389719) (← links)
- The effect of pay-for-performance in nursing homes: evidence from state Medicaid programs (Q36854193) (← links)
- Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study (Q37150471) (← links)
- Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia (Q37166113) (← links)
- Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities (Q37172915) (← links)
- State "technical assistance programs" for nursing home quality improvement: variations and potential implications (Q37201977) (← links)
- Bridging bench and practice: translational research for schizophrenia and other psychotic disorders (Q37284670) (← links)
- Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort (Q37306775) (← links)
- Impact of public reporting on quality of postacute care (Q37335696) (← links)
- The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature (Q37844624) (← links)
- An Evaluation of Performance Thresholds in Nursing Home Pay-for-Performance (Q39955447) (← links)
- Does organisational culture influence prescribing in care homes for older people? A new direction for research (Q40240752) (← links)
- Psychotropic use among older residents of board and care facilities (Q40376974) (← links)
- Antipsychotics in older patients. A safety perspective (Q40445523) (← links)
- Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes (Q40611802) (← links)
- Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education (Q40906260) (← links)
- Alcohol and drug misuse in the nursing home (Q41073350) (← links)
- Pharmacologic treatment of agitation in dementia: a comprehensive review (Q41169288) (← links)
- Lessons from geriatric psychiatry in the long-term care setting (Q41544430) (← links)
- Psychiatric assessments of nursing home residents under OBRA-87: should PASARR be reformed? Pre-Admission Screening and Annual Review (Q41610924) (← links)
- Prescribing patterns for nursing home residents in the US. The reality and the vision (Q41619927) (← links)
- Use of Antipsychotic Drugs in Nursing Homes: Current Compliance with OBRA Regulations (Q41706818) (← links)
- Antipsychotic Use in Dementia (Q41827089) (← links)
- Treatment of the agitation of late-life psychosis and Alzheimer's disease (Q43718354) (← links)
- Response to regulatory stringency: the case of antipsychotic medication use in nursing homes (Q44804861) (← links)
- Developing rehabilitative behavioral interventions for long-term care: technology transfer, acceptance, and maintenance issues. (Q45959538) (← links)